Ascelia Pharma AB (publ) (STO:ACE)
3.135
+0.005 (0.16%)
At close: Feb 27, 2026
-11.19% (1Y)
| Market Cap | 397.73M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -76.25M |
| Shares Out | 126.87M |
| EPS (ttm) | -0.67 |
| PE Ratio | n/a |
| Forward PE | 12.29 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 428,585 |
| Average Volume | 700,536 |
| Open | 3.130 |
| Previous Close | 3.130 |
| Day's Range | 3.060 - 3.150 |
| 52-Week Range | 2.305 - 5.230 |
| Beta | 0.84 |
| RSI | 54.99 |
| Earnings Date | Feb 5, 2026 |